1. Organ Procurement and Transplantation Network. Available at:. http://optn.transplant.hrsa.gov. Accessed Oct. 2014.

2. BusuttilRW, De CarlisLG, MihaylovPV, et al.The first report of orthotopic liver transplantation in the Western world. Am J Transplant2012;12:1385. CrossRef

3. WelchCS. A note on transplantation of the whole liver in dogs. Transplant Bull1955;2:54.

4. CannonJA. Brief report. Transplant Bull1956;3:7.

5. MooreFD, SmithLL, BurnapTK, et al.One‐stage homotransplantation of the liver following total hepatectomy in dogs. Transplant Bull1959;6:103. CrossRef

6. StarzlTE, KauppHAJ, BrockDR, et al.Studies on the rejection of the transplanted homologous dog liver. Surg Gynecol Obstet1961;112:135.

7. CalneRY, WhiteDJ, ThiruS, et al.Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet1978;2:1323. CrossRef

8. CalneRY, RollesK, WhiteDJ, et al.Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet1979;2:1033. CrossRef

9. StarzlTE, KlintmalmGB, PorterKA, et al.Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med1981;305:266. CrossRef

10. Liver transplantation. National Institutes of Health Consensus Development. Natl Inst Health Consens Dev Conf Summ1983;4:1.

11. D'AmicoG, Garcia‐TsaoG, PagliaroL. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol2006;44:217. CrossRef

12. de FranchisR. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol2005;43:167. CrossRef

13. PughRN, Murray‐LyonIM, DawsonJL, et al.Transection of the oesophagus for bleeding oesophageal varices. Br J Surg1973;60:646. CrossRef

14. MalinchocM, KamathPS, GordonFD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology2000;31:864. CrossRef

15. KamathPS, WiesnerRH, MalinchocM, et al.A model to predict survival in patients with end‐stage liver disease. Hepatology2001;33:464. CrossRef

16. HantoDW, FishbeinTM, PinsonCW, et al.Liver and intestine transplantation: summary analysis, 1994–2003. Am J Transplant2005;5:916. CrossRef

17. MartinAP, BartelsM, HaussJ, et al.Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc2007;39:3169. CrossRef

18. KimWR, BigginsSW, KremersWK, et al.Hyponatremia and mortality among patients on the liver‐transplant waiting list. N Engl J Med2008;359:1018. CrossRef

19. FreemanRB. Mathematical models and behavior: assessing delta MELD for liver allocation. Am J Transplant2004;4:1735. CrossRef

20. FreemanRBJ, GishRG, HarperA, et al.Model for end‐stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl2006;12:S128. CrossRef

21. MerionRM, SchaubelDE, DykstraDM, et al.The survival benefit of liver transplantation. Am J Transplant2005;5:307. CrossRef

22. NairS, VermaS, ThuluvathPJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology2002;35:105. CrossRef

23. FoxAN, VagefiPA, StockPG. Liver transplantation in HIV patients. Semin Liver Dis2012;32:177. CrossRef

24. ReichDJ, MunozSJ, RothsteinKD, et al.Controlled non‐heart‐beating donor liver transplantation: a successful single center experience, with topic update. Transplantation2000;70:1159. CrossRef

25. AbtPL, DesaiNM, CrawfordMD, et al.Survival following liver transplantation from non‐heart‐beating donors. Ann Surg2004;239:87. CrossRef

26. PichlmayrR, RingeB, GubernatisG, et al.[Transplantation of a donor liver to 2 recipients (splitting transplantation)–a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir1988;373:127. CrossRef

27. CauleyRP, VakiliK, FullingtonN, et al.Deceased‐donor split‐liver transplantation in adult recipients: is the learning curve over?J Am Coll Surg2013;217:672. CrossRef

28. DoyleMB, MaynardE, LinY, et al.Outcomes with split liver transplantation are equivalent to those with whole organ transplantation. J Am Coll Surg2013;217:102; discussion 113. CrossRef

29. BergCL, GillespieBW, MerionRM, et al.Improvement in survival associated with adult‐to‐adult living donor liver transplantation. Gastroenterology2007;133:1806. CrossRef

30. FreiseCE, GillespieBW, KoffronAJ, et al.Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant2008;8:2569. CrossRef

31. MossAH, SieglerM. Should alcoholics compete equally for liver transplantation?JAMA1991;265:1295. CrossRef

32. TandonP, GoodmanKJ, MaMM, et al.A shorter duration of pre‐transplant abstinence predicts problem drinking after liver transplantation. Am J Gastroenterol2009;104:1700. CrossRef

33. EverhartJE, BeresfordTP. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg1997;3:220. CrossRef

34. MathurinP, MorenoC, SamuelD, et al.Early liver transplantation for severe alcoholic hepatitis. N Engl J Med2011;365:1790. CrossRef

35. LimJK, KeeffeEB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl2004;10:S31. CrossRef

36. CuadradoA, FabregaE, CasafontF, et al.Alcohol recidivism impairs long‐term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl2005;11:420. CrossRef

37. Garcia‐RetortilloM, FornsX, FeliuA, et al.Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology2002;35:680. CrossRef

38. FormanLM, LewisJD, BerlinJA, et al.The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology2002;122:889. CrossRef

39. BerenguerM. Natural history of recurrent hepatitis C. Liver Transpl2002;8:S14. CrossRef

40. GaneEJ, PortmannBC, NaoumovNV, et al.Long‐term outcome of hepatitis C infection after liver transplantation. N Engl J Med1996;334:815. CrossRef

41. GaneEJ. The natural history of recurrent hepatitis C and what influences this. Liver Transpl2008;14(Suppl 2):S36. CrossRef

42. EversonGT, TrotterJ, FormanL, et al.Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology2005;42:255. CrossRef

43. TodoS, DemetrisAJ, Van ThielD, et al.Orthotopic liver transplantation for patients with hepatitis B virus‐related liver disease. Hepatology1991;13:619.

44. KimWR, PoteruchaJJ, KremersWK, et al.Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl2004;10:968. CrossRef

45. FoxAN, TerraultNA. The option of HBIG‐free prophylaxis against recurrent HBV. J Hepatol2012;56:1189. CrossRef

46. GraziadeiIW, WiesnerRH, MarottaPJ, et al.Long‐term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology1999;30:1121. CrossRef

47. SoetiknoRM, LinOS, HeidenreichPA, et al.Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta‐analysis. Gastrointest Endosc2002;56:48. CrossRef

48. SinghS, VarayilJE, LoftusEVJ, et al.Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta‐analysis. Liver Transpl2013;19:1361. CrossRef

49. BurakK, AnguloP, PashaTM, et al.Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol2004;99:523. CrossRef

50. HeimbachJK, GoresGJ, HaddockMG, et al.Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis2004;24:201. CrossRef

51. DicksonER, GrambschPM, FlemingTR, et al.Prognosis in primary biliary cirrhosis: model for decision making. Hepatology1989;10:1. CrossRef

52. Liermann GarciaRF, Evangelista GarciaC, McMasterP, et al.Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology2001;33:22. CrossRef

53. MazzaferroV, RegaliaE, DociR, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med1996;334:693. CrossRef

54. YaoFY, FerrellL, BassNM, et al.Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology2001;33:1394. CrossRef

55. YaoFY, HiroseR, LaBergeJM, et al.A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl2005;11:1505. CrossRef

56. KemmerN, KaiserT, ZachariasV, et al.Alpha‐1‐antitrypsin deficiency: outcomes after liver transplantation. Transplant Proc2008;40:1492. CrossRef

57. KowdleyKV, BrandhagenDJ, GishRG, et al.Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology2005;129:494. CrossRef

58. TungBY, FarrellFJ, McCashlandTM, et al.Long‐term follow‐up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg1999;5:369. CrossRef

59. MediciV, MiranteVG, FassatiLR, et al.Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl2005;11:1056. CrossRef

60. WilliamsCD, StengelJ, AsikeMI, et al.Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle‐aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology2011;140:124. CrossRef

61. CharltonMR, BurnsJM, PedersenRA, et al.Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology2011;141:1249. CrossRef

62. SchrammC, BubenheimM, AdamR, et al.Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl2010;16:461.

63. VogelA, HeinrichE, BahrMJ, et al.Long‐term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant2004;18:62. CrossRef

64. PradosE, Cuervas‐MonsV, de la MataM, et al.Outcome of autoimmune hepatitis after liver transplantation. Transplantation1998;66:1645. CrossRef

65. RatziuV, SamuelD, SebaghM, et al.Long‐term follow‐up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol1999;30:131. CrossRef

66. LarsonAM, PolsonJ, FontanaRJ, et al.Acetaminophen‐induced acute liver failure: results of a United States multicenter, prospective study. Hepatology2005;42:1364. CrossRef

67. O'GradyJG, AlexanderGJ, HayllarKM, et al.Early indicators of prognosis in fulminant hepatic failure. Gastroenterology1989;97:439.

68. BernuauJ, GoudeauA, PoynardT, et al.Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology1986;6:648. CrossRef

69. KatoonizadehA, DecaesteckerJ, WilmerA, et al.MELD score to predict outcome in adult patients with non‐acetaminophen‐induced acute liver failure. Liver Int2007;27:329. CrossRef

70. SchmidtLE, LarsenFS. MELD score as a predictor of liver failure and death in patients with acetaminophen‐induced liver injury. Hepatology2007;45:789. CrossRef

71. AscherNL, LakeJR, EmondJC, et al.Liver transplantation for fulminant hepatic failure. Arch Surg1993;128:677. CrossRef

72. LakeJ, PatelD, DavidK, et al.The association between MMF and risk of progressive renal dysfunction and death in adult liver transplant recipients with HCV. Clin Transplant2009;23:108. CrossRef

73. YooHY, MaheshwariA, ThuluvathPJ. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transpl2003;9:897. CrossRef

74. UemuraT, RandallHB, SanchezEQ, et al.Liver retransplantation for primary nonfunction: analysis of a 20‐year single‐center experience. Liver Transpl2007;13:227. CrossRef

75. BekkerJ, PloemS, de JongKP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant2009;9:746. CrossRef

76. NishidaS, KatoT, LeviD, et al.Effect of protocol Doppler ultrasonography and urgent revascularization on early hepatic artery thrombosis after pediatric liver transplantation. Arch Surg2002;137:1279. CrossRef

77. DuffyJP, HongJC, FarmerDG, et al.Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg2009;208:896; discussion 903. CrossRef

78. ShahSA, GrantDR, McGilvrayID, et al.Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center. Am J Transplant2007;7:161. CrossRef

79. AabakkenL, BretthauerM, LinePD. Double‐balloon enteroscopy for endoscopic retrograde cholangiography in patients with a Roux‐en‐Y anastomosis. Endoscopy2007;39:1068. CrossRef

80. JueTL, ImperialJC. Management of post‐liver‐transplant biliary strictures: a work in progress. Gastrointest Endosc2008;67:886. CrossRef

81. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology1997;25:658. CrossRef

82. WiesnerRH, DemetrisAJ, BelleSH, et al.Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology1998;28:638. CrossRef

83. UemuraT, IkegamiT, SanchezEQ, et al.Late acute rejection after liver transplantation impacts patient survival. Clin Transplant2008;22:316. CrossRef

84. ZhongL, MenTY, LiH, et al.Prevalence and risk factor for MDR‐GNB infection in liver transplantation. Front Biosci (Landmark Ed)2013;18:366. CrossRef

85. ZhongL, MenTY, LiH, et al.Multidrug‐resistant gram‐negative bacterial infections after liver transplantation – spectrum and risk factors. J Infect2012;64:299. CrossRef

86. RazonableRR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol2008;14:4849. CrossRef

87. SalibaF, DelvartV, IchaiP, et al.Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transplant2013;27:E454. CrossRef

88. DemetrisA, AdamsD, BellamyC, et al.Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology2000;31:792. CrossRef

89. KremersWK, DevarbhaviHC, WiesnerRH, et al.Post‐transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. Am J Transplant2006;6:1017. CrossRef

90. SchremH, KurokM, KaltenbornA, et al.Incidence and long‐term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl2013;19:1252. CrossRef

91. HerreroJI, EspanaA, QuirogaJ, et al.Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl2005;11:1100. CrossRef

92. GonwaTA. Hypertension and renal dysfunction in long‐term liver transplant recipients. Liver Transpl2001;7(Suppl 1):S22. CrossRef

93. PalmerM, SchaffnerF, ThungSN. Excessive weight gain after liver transplantation. Transplantation1991;51:797. CrossRef

94. RichardsJ, GunsonB, JohnsonJ, et al.Weight gain and obesity after liver transplantation. Transpl Int2005;18:461. CrossRef

95. AkarsuM, BakirY, KarademirS, et al.Prevalence and risk factors for obesity after liver transplantation: a single‐center experience. Hepat Mon2013;13:e7569.

96. MoonJI, BarbeitoR, FaradjiRN, et al.Negative impact of new‐onset diabetes mellitus on patient and graft survival after liver transplantation: long‐term follow up. Transplantation2006;82:1625. CrossRef

97. BaidS, CosimiAB, FarrellML, et al.Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation2001;72:1066. CrossRef

98. JohnPR, ThuluvathPJ. Outcome of patients with new‐onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl2002;8:708. CrossRef

99. GisbertC, PrietoM, BerenguerM, et al.Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg1997;3:416. CrossRef

100. CanzanelloVJ, SchwartzL, TalerSJ, et al.Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg1997;3:1. CrossRef

101. SanchezEQ, MartinAP, IkegamiT, et al.Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years. Transplant Proc2005;37:4416. CrossRef

102. MartinJE, CavanaughTM, TrumbullL, et al.Incidence of adverse events with HMG‐CoA reductase inhibitors in liver transplant patients. Clin Transplant2008;22:113. CrossRef

103. OjoAO, HeldPJ, PortFK, et al.Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med2003;349:931. CrossRef

104. GonwaTA, MaiML, MeltonLB, et al.End‐stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin‐based immunotherapy: risk of development and treatment. Transplantation2001;72:1934. CrossRef

105. SharmaP, SchaubelDE, GuidingerMK, et al.Impact of MELD‐based allocation on end‐stage renal disease after liver transplantation. Am J Transplant2011;11:2372. CrossRef

106. NankivellBJ, BorrowsRJ, FungCL, et al.The natural history of chronic allograft nephropathy. N Engl J Med2003;349:2326. CrossRef

107. NairS, EasonJ, LossG. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Liver Transpl2003;9:126. CrossRef

108. AlegreC, JimenezC, ManriqueA, et al.Everolimus monotherapy or combined therapy in liver transplantation: indications and results. Transplant Proc2013;45:1971. CrossRef

109. WiesnerR, EdwardsE, FreemanR, et al.Model for end‐stage liver disease (MELD) and allocation of donor livers. Gastroenterology2003;124:91. CrossRef

110. MurrayKF, CarithersRLJ. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology2005;41:1407. CrossRef

111. Scientific Registry of Transplant Recipients. Total Liver Transplants, 2012. Available at: http://srtr.transplant.hrsa.gov/annual_reports/2012/Default.aspx. Accessed July 2014.